Coincidentally, miR-195 has been identified as a potential therapeutic target in osteosarcoma treatment due to its ability to inhibit CCND1, thereby exhibiting tumor metastasis suppressor properties [25]. The gene discussed is CCND1; the disease is neoplasm.